A comprehensive review on past, present and future aspects of canine theileriosis.
Azithromycin
Buparvaquone
Canine
Ixodes hexagonus, atovaquone
Theileria annae
Theileria annulata
Theileria equi
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
02
08
2018
revised:
25
10
2018
accepted:
26
10
2018
pubmed:
6
11
2018
medline:
26
2
2019
entrez:
3
11
2018
Statut:
ppublish
Résumé
Canine theileriosis is a notorious tick borne piroplasmid infection of wild and domestic canines. The causative agent has not yet been accurately classified. PCR studies revealed that causative agent resembles to Theileria genus and thus provisionally named as Theileria annae. The other Theileria species reported in canines is Theileria annulata, Theileria equi and unnamed Theileria specie. This emergent canine infection is considered to be endemic in most of the European countries. However in Asia this disease has not been reported till date. The vectors responsible for transmission of this disease have not been determined. It has been suggested that DNA of Theileria annae has been detected in hard tick Ixodes hexagonus in Northwestern Spain and several other tick species. Clinically canine theileriosis is characterized by severe weakness, fever, hemoglobinuria and anemia. Recently atovaquone or buparvaquone plus azithromycin therapy showed better clinical efficacy. This comprehensive review is intended to summarize the current knowledge on prevalence and epidemiology of canine theileriosis in different countries of the world and associated tick vectors.
Identifiants
pubmed: 30385396
pii: S0882-4010(18)31373-1
doi: 10.1016/j.micpath.2018.10.033
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
116-122Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.